RANDALL CAMPBELL: Open Payments
NPI 1487868576 · TIFTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$987 in 52 payments from 17 companies in 2025. Trend: 2023 $1,026 · 2024 $860 · 2025 $987
Food & beverage: $987
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 9 | $199 |
| AstraZeneca Pharmaceuticals LP | 7 | $136 |
| Novo Nordisk Inc | 6 | $120 |
| Lilly USA, LLC | 6 | $96 |
| ABBVIE INC. | 4 | $73 |
| Amgen Inc. | 4 | $61 |
| GlaxoSmithKline, LLC. | 3 | $60 |
| Dexcom, Inc. | 2 | $49 |
| Paratek Pharmaceuticals, Inc. | 3 | $48 |
| Eisai Inc. | 1 | $29 |
Products named: Korlym, MOUNJARO, BREZTRI, Wegovy, OTEZLA, TRELEGY ELLIPTA, Dexcom G6 Transmitter, AIRSUPRA.
Industry payments across GA — which companies pay providers there.
